89 related articles for article (PubMed ID: 20199027)
41. Atomic view of the histidine environment stabilizing higher-pH conformations of pH-dependent proteins.
Valéry C; Deville-Foillard S; Lefebvre C; Taberner N; Legrand P; Meneau F; Meriadec C; Delvaux C; Bizien T; Kasotakis E; Lopez-Iglesias C; Gall A; Bressanelli S; Le Du MH; Paternostre M; Artzner F
Nat Commun; 2015 Jul; 6():7771. PubMed ID: 26190377
[TBL] [Abstract][Full Text] [Related]
42. Exploring the sequence space for (tri-)peptide self-assembly to design and discover new hydrogels.
Frederix PW; Scott GG; Abul-Haija YM; Kalafatovic D; Pappas CG; Javid N; Hunt NT; Ulijn RV; Tuttle T
Nat Chem; 2015 Jan; 7(1):30-7. PubMed ID: 25515887
[TBL] [Abstract][Full Text] [Related]
43. A redox responsive, fluorescent supramolecular metallohydrogel consists of nanofibers with single-molecule width.
Zhang Y; Zhang B; Kuang Y; Gao Y; Shi J; Zhang XX; Xu B
J Am Chem Soc; 2013 Apr; 135(13):5008-11. PubMed ID: 23521132
[TBL] [Abstract][Full Text] [Related]
44. Control of peptide nanotube diameter by chemical modifications of an aromatic residue involved in a single close contact.
Tarabout C; Roux S; Gobeaux F; Fay N; Pouget E; Meriadec C; Ligeti M; Thomas D; IJsselstijn M; Besselievre F; Buisson DA; Verbavatz JM; Petitjean M; Valéry C; Perrin L; Rousseau B; Artzner F; Paternostre M; Cintrat JC
Proc Natl Acad Sci U S A; 2011 May; 108(19):7679-84. PubMed ID: 21518895
[TBL] [Abstract][Full Text] [Related]
45. Directing peptide crystallization through curvature control of nanotubes.
Gobeaux F; Tarabout C; Fay N; Meriadec C; Ligeti M; Buisson DA; Cintrat JC; Artzner F; Paternostre M
J Pept Sci; 2014 Jul; 20(7):508-16. PubMed ID: 24916887
[TBL] [Abstract][Full Text] [Related]
46. Self-assembly of the octapeptide lanreotide and lanreotide-based derivatives: the role of the aromatic residues.
Pandit A; Fay N; Bordes L; Valéry C; Cherif-Cheikh R; Robert B; Artzner F; Paternostre M
J Pept Sci; 2008 Jan; 14(1):66-75. PubMed ID: 17929329
[TBL] [Abstract][Full Text] [Related]
47. Biomimetic organization: Octapeptide self-assembly into nanotubes of viral capsid-like dimension.
Valéry C; Paternostre M; Robert B; Gulik-Krzywicki T; Narayanan T; Dedieu JC; Keller G; Torres ML; Cherif-Cheikh R; Calvo P; Artzner F
Proc Natl Acad Sci U S A; 2003 Sep; 100(18):10258-62. PubMed ID: 12930900
[TBL] [Abstract][Full Text] [Related]
48. Self-association process of a peptide in solution: from beta-sheet filaments to large embedded nanotubes.
Valéry C; Artzner F; Robert B; Gulick T; Keller G; Grabielle-Madelmont C; Torres ML; Cherif-Cheikh R; Paternostre M
Biophys J; 2004 Apr; 86(4):2484-501. PubMed ID: 15041685
[TBL] [Abstract][Full Text] [Related]
49. Atomic structure of Lanreotide nanotubes revealed by cryo-EM.
Pieri L; Wang F; Arteni AA; Vos M; Winter JM; Le Du MH; Artzner F; Gobeaux F; Legrand P; Boulard Y; Bressanelli S; Egelman EH; Paternostre M
Proc Natl Acad Sci U S A; 2022 Jan; 119(4):. PubMed ID: 35042822
[TBL] [Abstract][Full Text] [Related]
50. Elucidation of the self-assembly pathway of lanreotide octapeptide into beta-sheet nanotubes: role of two stable intermediates.
Pouget E; Fay N; Dujardin E; Jamin N; Berthault P; Perrin L; Pandit A; Rose T; Valéry C; Thomas D; Paternostre M; Artzner F
J Am Chem Soc; 2010 Mar; 132(12):4230-41. PubMed ID: 20199027
[TBL] [Abstract][Full Text] [Related]
51. Design and properties of functional nanotubes from the self-assembly of cyclic peptide templates.
Chapman R; Danial M; Koh ML; Jolliffe KA; Perrier S
Chem Soc Rev; 2012 Sep; 41(18):6023-41. PubMed ID: 22875035
[TBL] [Abstract][Full Text] [Related]
52. Role of peptide self-assembly in antimicrobial peptides.
Tian X; Sun F; Zhou XR; Luo SZ; Chen L
J Pept Sci; 2015 Jul; 21(7):530-9. PubMed ID: 26100854
[TBL] [Abstract][Full Text] [Related]
53. Peptide Self-Assemblies for Drug Delivery.
Leite DM; Barbu E; Pilkington GJ; Lalatsa A
Curr Top Med Chem; 2015; 15(22):2277-89. PubMed ID: 26043734
[TBL] [Abstract][Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
